Message from John England, MD AUPN President
Most of us who manage Neurology residency and fellowship programs are in candidate interviews. Virtual interviews are now the norm. For better or worse, it is difficult to envision a return to in-person interviews for candidates. We can talk more about this topic at the 2025 AUPN meeting in Baltimore. As we enter the upcoming Holiday Season, most of us will have some time to reflect upon the past year and plan for the future. Along those lines, Chairs, please remember to pay your 2025 institutional dues to AUPN. Dues are a major source of our revenue and allow us to continue providing services including the now yearly AUPN meeting.
A few other notices are highlighted below.
|
AUPN Dues Reminder
As a gentle reminder, AUPN has started its dues solicitation for 2025. We encourage all Chairs to pay their annual dues, ensure that their institutional profile is updated, and that they have identified all seven (7) individuals at their institution who they wish to include in the annual membership. Instructions for adding individuals to your institution’s profile can be found on the member welcome page after logging into your AUPN account. If you need assistance, please contact neuro@aupn.org.
Thank you in advance for your continued support of AUPN!
|
New Chair of Neurology
Jose Romano, MD has been named Chair of Neurology at the University of Miami Miller School of Medicine. Dr. Romano is an internationally recognized expert in vascular neurology. He joined the University of Miami Miller School of Medicine in 1997 and has remained on the faculty since that time. In 2008, he was named the Director of Jackson Memorial Hospital’s comprehensive stroke center and in 2011 was named the Medical Director of Neurology. He served as the Interim Chair of the department from January 2023 until his recent appointment as formal Chair.
Please congratulate Dr. Romano on his new appointment!
|
Educational Training Opportunities
Applications are now being accepted for the ENLIGHTEN (ENgaging Leaders In Global and local HealTh Equity in Neurology) Fellowship Program. This program will provide hands-on research experience and training in health equity. It is sponsored by a National Institute of Neurological Disorders and Stroke (NINDS) T32 award. ENLIGHTEN will support two US post-doctoral fellowships (clinician researchers and PhD scientists) per year for a 2-year fellowship. Applications are now being accepted until December 31, 2024. For Questions, email enlighten@ucsf.edu.
Applications are still being accepted for the 2025 Training in Neurotherapeutics Discovery and Development for Academic Scientists Course, which will be held on March 25-28, 2025 at the University of California, Davis. The application deadline is December 9, 2024. The application is free; and registration, travel and lodging costs are fully covered for accepted applicants.
The course, which is funded by the NIH, teaches academic neurologists the principles of drug discovery and development and how neurotherapeutic drugs are discovered, characterized, and tested so that they can enter clinical trials.
To review the application criteria and apply online click here.
|
Leadership Minute
This month’s Leadership Minute is entitled “How to Support Education and Research”. The featured speaker myself, John D. England, MD at LSU Health Sciences Center School of Medicine in New Orleans, and the moderator is Mud Alvi, MD at West Virginia University. This podcast will provide suggestions that may help departments support education and research. The ability to fund these activities varies and is institutionally specific. Examples of funding sources will be discussed.
|
Leading Edge Podcast
This quarter's Leading Edge Podcast is entitled “American Heart Association (AHA) Efforts to Fund Brain Health Research”. The featured speaker is Mitchell Elkind, MD, Chief Clinical Science Officer for the American Heart Association, and the moderator is Shreyas Gangadhara, MD at the University of Mississippi Medical Center. In this podcast, Dr. Elkind discusses the AHA’s growing programs in brain health and neuroscience. The AHA is developing research, awareness, advocacy, and quality programs in cognitive impairment and dementia, migraine, epilepsy, mental health, and other areas of interest to neuroscientists and clinicians, including neurologists. Dr. Elkind will discuss research funding opportunities available through the American Heart Association, which now considers brain health one of its core areas of research funding together with cardiovascular disease and stroke.
|
Best regards,
John D. England, MD
AUPN President
AUPN encourages you to forward this newsletter to other faculty in your department, or anyone else who might benefit from our programs.
|
Open Neurology Leadership Positions
|
|
|
|
|
|